Legato Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,793
Closed -$416K 863
2026
Q1
$416K Sell
3,793
-3,254
-46% -$463K 0.04% 566
2025
Q4
$1.17M Buy
7,047
+982
+16% +$164K 0.1% 315
2025
Q3
$1.19M Sell
6,065
-4,743
-44% -$780K 0.13% 246
2025
Q2
$977K Buy
10,808
+5,691
+111% +$450K 0.12% 279
2025
Q1
$305K Sell
5,117
-20,495
-80% -$1.9M 0.04% 486
2024
Q4
$3.39M Buy
25,612
+10,386
+68% +$975K 0.44% 31
2024
Q3
$798K Buy
15,226
+11,801
+345% +$554K 0.1% 357
2024
Q2
$207K Buy
+3,425
New +$238K 0.03% 519

Other funds holding ALAB

Legato Capital Management's ALAB Position: Q2 2026 in Review

Legato Capital Management sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 3,793 shares — an estimated $416K sold.

Legato Capital Management first reported a position in ALAB in Q2 2024 and held it in 8 quarters. The position peaked at $3.39M in Q4 2024. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Legato Capital Management reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • Legato Capital Management sold 3,793 Astera Labs shares in Q2 2026, an estimated $416K.
  • Legato Capital Management first reported a position in Astera Labs in Q2 2024 and held it in 8 quarters.
  • Legato Capital Management's Astera Labs position peaked at $3.39M in Q4 2024.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.